Artur Donimirski

Kane Biotech's Stellar Q3 Performance Kane Biotech has announced its impressive financial results for the third quarter of 2024, highlighted by the celebrated commercial launch of their revyve™ Wound Gel.…

**Sana Biotechnology's Bold December Move: What You Need to Know** Sana Biotechnology, Inc. (NASDAQ: SANA) is set to unveil some exciting updates. The company, renowned for its pioneering work on…